The GO/Gj to S transition in quiescent BALB/c 3T3 cells stimulated by serum growth factors can be specifically blocked by the administration ofinterferon (IFN) to the system. In the present communication, we studied whether IFN inhibits the early events in the Go/G1 phase that are initiated by the platelet-derived growth factor (PDGF). The results show that IFN inhibits most of the PDGF-mediated increase of c-myc, ornithine decarboxylase, and j3-actin mRNAs measured 3 hr after stimulation. c-fos mRNA levels are reduced by IFN as early as 20 min after exposure of the quiescent cells to PDGF. The expression of several genes that belong to the competence gene family is, therefore, inhibited by IFN and this could account for the failure of the IFN-treated cells to enter into the S phase when growth factors present in the platelet-poor plasma are added. We also report that the PDGF-mediated increase in the uptake of deoxyglucose is not impaired by IFN, thus suggesting that the early effects of IFN on gene expression do not result from inhibition of binding of PDGF to its cell-surface receptors. Unlike the direct stimulatory effect ofPDGF, which is not sensitive to cycloheximide, the inhibitory effect of IFN on c-myc mRNA levels depends in part on protein synthesis. We propose that a putative product of one of the IFN-induced genes could mediate the decrease in expression of the PDGF-regulated gene family.
Go/Gj phase undergo a synchronous progression through the cell cycle by the addition of serum or a combination of growth-promoting factors (for review, see ref. 1). Plateletderived growth factor (PDGF) is the serum component that renders BALB/c 3T3 cells "competent" to undergo DNA synthesis (2). A second set of growth factors contained in the platelet-poor fraction ofplasma functions synergistically with PDGF to promote the optimum mitogenic response in these cells. PDGF activates directly the expression of several genes, and at least five independent members of a PDGFinducible gene family have been isolated by molecular cloning techniques (3) . Moreover, two oncogenes that encode nuclear proteins, c-myc and c-fos, seem to belong to the competence gene family in 3T3 cells (4) (5) (6) (7) . Thus, the level of c-myc mRNA increases >40-fold several hours after the addition of PDGF to the culture medium of the quiescent 3T3 cells (4, 5) . The induction of the c-fos gene precedes the activation of the c-myc gene and is maximal [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] min after exposure of the cells to PDGF (6, 7) . In addition, the levels of ornithine decarboxylase (OrnDCase) mRNA are also rapidly induced after serum stimulation of 3T3 cells, as recently shown by using the corresponding cloned cDNA encoding this first enzyme in polyamine biosynthesis (8) .
The interferons (IFNs) represent one of the first welldefined groups of proteins that exhibit antimitogenic effects on cells (for review, see ref. 9 ). Some IFNs may be classified as natural growth inhibitors, considering our previous reports showing that hematopoietic cells produce A-related IFNs that operate in an autocrine fashion when they become arrested at the Go/G1 phase as part of their terminal differentiation (10, 11) . The growth of the mammalian cells seems therefore to be regulated by natural growth inhibitors in addition to the growth-promoting factors. Indeed, it is well established that the administration of IFN concomitant with serum or a combination of growth factors to the quiescent 3T3 cells delays or completely blocks the Go/G1 to S transition (12) (13) (14) (15) .
In addition, the antimitogenic effect of IFN on some cycling cells also results from a specific Go/Gj arrest of cells (16, 17) .
It is interesting that both growth factors and IFN exert their function on cells through binding to specific cell-surface receptors, and in each case the membrane changes lead to rapid nuclear events by as yet unknown mechanisms. The IFN, however, turns on a distinct group of genes (18) (19) (20) different from those induced by PDGF. The Go/G1 to S transition of BALB/c 3T3 fibroblasts therefore provides an attractive model for analyzing the basis of the antagonistic effects of growth factors and growth inhibitors on cell proliferation. In this work, we studied whether IFN decreases the expression of genes that are turned on by the competence growth factor, PDGF, and that may function as the intracellular mediators of the mitogenic response. We report here that (i) IFN (16) .
RNA Electrophoresis, Transfer, and Hybridization. Twenty micrograms of total cellular RNA was electrophoresed on a 1% agarose gel/6% formaldehyde, transferred onto nitrocellulose, dried, and baked as described (11) . Hybridization to 107 cpm of each of the different probes, radiolabeled by nick-translation to a specific activity of 0.5-2 x 108 cpm/,hg was performed as described (11) . Filters were exposed to x-ray films, and the intensity of the bands was quantitated by densitometric scanning with a UV/8 spectrophotometer (Beckman).
Uptake of Deoxyglucose. Plates (3 cm) were incubated for 15 min in 1.5 ml of glucose-free medium before adding 2-[3H]deoxyglucose (0.2 mM; 2.5 uCi/ml). After (25) . PDGF activity was quantitated in our cells by the assay of stimulation of DNA synthesis performed in the presence of 2.5% platelet-poor plasma, and 1 unit was defined as described (2, 25). Mouse IFN (a and ,B) (specific activity, 2 x 107 units per mg of protein) was purchased from Enzo Biochemicals (New York). The IFN was titered by using a cytopathic effect inhibition assay with vesicular stomatitis virus in L929 cells (10) . Mouse IFN international standard, supplied by the National Institutes of Health, was used as a reference.
RESULTS
We have used in these studies density-arrested monolayers of BALB/c 3T3 cells that were incubated overnight in medium depleted of growth factors. Fig. 1 illustrates the kinetics of DNA synthesis after serum stimulation of the quiescent cells and also shows the inhibitory effects of IFN on this profile when the latter is added simultaneously with the serum. DNA synthesis was initiated 12-15 hr after stimulation. The cell system used in this work displayed an extremely high sensitivity to IFN: a few units per ml of mouse IFN were sufficient to reduce the incorporation of [3H]thymidine into Increasing amounts of IFN were added at time 0, and DNA synthesis was measured 17 hr after serum stimulation.
DNA by >50%, as calculated from the dose-response curve (Fig. 1 Inset) . No loss of cell viability could be detected up to 25 hr after IFN treatment (not shown). Table 1 shows that the IFN exerted similar inhibitory effects when the mitogenic stimulation was divided into two steps and consisted of a 3-hr pulse with PDGF and subsequent incubation of the cells in 2.5a platelet-poor plasma.
It is well established from previous work that reduction by IFN in the incorporation of [3H]thymidine into the trichloroacetic acid-insoluble fraction of 3T3 cells reflects, in part, a decline in the nuclear labeling index that results from a block, or delay, in the progression of cells from GT/G1 to the S phase (12, 21) . We have also reported in the past that most of the inhibitory effects of IFN on DNA synthesis in this cell system were lost if the latter was added 5-10 hr after serum stimulation (21) . We therefore studied in this work whether IFN inhibits the early events in the Go/G1 phase that are specifically stimulated by the competence factor PDGF. We started by measuring the effect of IFN on c-myc expression.
Total RNA was extracted from cell monolayers, harvested before and after 3 hr of treatment with PDGF, and analyzed for c-myc mRNA levels by RNA blot transfer and hybridization to c-myc DNA sequences. c-myc mRNA levels that were under the limit of detection in the quiescent cells were strongly increased in response to the PDGF, as was expected from previous reports (4) (Fig. 2) . However, the addition of mouse IFN at 100 units/ml together with the growth factor prevented most of the increase in the c-myc mRNA levels detected after 3 hr (Fig. 2) . Densitometer tracing of the autoradiograph indicated that IFN decreased the concentration of c-myc mRNA in the PDGF-stimulated cells by 95% (Table 1) .
The gene that encodes the OrnDCase enzyme is also rapidly activated during the progression of 3T3 cells from quiescence to growth. The blot analyzed in Fig. 2 was stripped of the c-myc probe and hybridized to the OrnDCase cDNA probe recently isolated by Kahana and Nathans (8) . This probe detects a major band of 2.4 kb and a minor band of 2.6 kb. Fig. 2 shows that the levels of OrnDCase mRNA were markedly increased by PDGF and that IFN abolished by 90% the expression of this gene. Similar inhibitory effects of IFN were measured when a third gene, which is directly stimulated by PDGF, the ,B-actin (6) , was analyzed (Fig. 2) .
It should be mentioned that the extent of inhibition by IFN with respect to the expression of these three genes varied The uptake of deoxyglucose was measured before and 1 hr and 3 hr after the exposure of quiescent cells to PDGF (20 units/ml) or to a combination of PDGF and IFN. c-myc mRNA levels were determined by scanning the autoradiograph in Fig. 2 ; the area below each peak was calculated. Three hours after administration of PDGF with or without IFN, 2.5% platelet-poor plasma was added to the culture medium together with 10 ACi of [3H]thymidine per ml. Incorporation into trichloroacetic acid-insoluble fraction was determined 20 hr after stimulation. ND, not detected.
depending on the concentration of PDGF used and that maximal effects were obtained with PDGF at 20 units/ml, as described in Fig. 2 . We also detected similar inhibitory effects of IFN on the expression of these genes when 15 ng of homogenous porcine PDGF per ml was used (data not shown).
Since the induction of c-fos mRNA by PDGF is maximal at 10-20 min and decreases thereafter (6, 7), we performed an additional experiment where total RNA was extracted from the 3T3 monolayers 20 min after exposure to PDGF at 20 units/ml. Here also, the IFN (100 units/ml) was administrated to the cells concomitant with the PDGF. Fig. 2 shows that under these conditions the expression of a 2.2-kb c-fos mRNA was decreased by -50%. In another experiment, IFN inhibited the serum-mediated increase of c-fos mRNA levels by 80% (not shown). It seems that under the conditions used in these experiments IFN disrupted the process of competence by preventing the increase in the expression of the PDGF-induced genes, and this could account for the failure of these cells to further enter into the S phase when additional growth factors present in the platelet-poor plasma were supplied to the system (Table 1) .
In contrast to the inhibitory effect ofIFN on the expression of the competence gene family, the PDGF-mediated increase It has been reported that the induction of c-myc mRNA occurs in the presence of cycloheximide and, therefore, does not require the synthesis of new protein species (4). In the experiment described in Fig. 3 , the quiescent cells were exposed to PDGF or to a combination of PDGF and IFN in the presence or absence of cycloheximide (10 ,g/ml). As expected, the cycloheximide did not prevent the induction of c-myc mRNA by PDGF. In contrast, the inhibitory effect of IFN on c-myc mRNA levels was partially dependent on protein synthesis, because the extent of inhibition by IFN was much smaller in the presence of the drug (Fig. 3) . The extent of reduction by IFN as measured by scanning densitometry of different exposures of the fims was 24% and 85% in the presence and absence of cycloheximide, respectively. These results, therefore, suggest that the synthesis of (26, 27) , it has been suggested that the nuclear protein products of the normal counterparts of these genes may function as intracellular mediators of the mitogenic response to the PDGF. In this respect, it has been recently shown by DNA-mediated gene transfer experiments that the c-myc gene product mediates the acquirement of the "competent state" in 3T3 cells (28) . We therefore suggest that the inhibitory effects of IFN on the expression of the PDGFinduced genes measured early after the stimulation process may account, at least in part, for its well-known antimitogenic effects in this system-i.e., for the decrease in the rate of entry into S phase. Antagonism in action between IFN and PDGF was suggested in the past by showing that IFN inhibited the mitogenic effect of PDGF in several cell systems and, conversely, excess amounts of PDGF abolished the anticellular effects of IFN (29) . BALB/c 3T3 cells produce small quantities of IFN and respond to it in an autocrine fashion when they reach confluency (unpublished results). It therefore seems that PDGF (20 units/ml) counteracted the antimitogenic e'ect of this endogenous IFN but failed to do so when excess exogenous IFN (100 units/ml) was further supplied to the system. The quantitative balance between PDGF and IFN determines the extent of expression of the competence gene family and thus the probability of cells to either stay in the quiescent state or to further proceed through the cell cycle.
Sreevalsan Vt al. (14, 15) have reported that IFN exerts a differential effect on the biochemical events that take place during the Go/Gl to S transition stimulated by serum or some growth factors. In this respect, the authors have shown that while IFN inhibited the increase in OrnDCase enzyme activity and the second phase of Pi uptake, no effect on the uptake of deoxyglucose could be detected. It was, therefore, important to measure the effect of IFN on the PDGFmediated increase in the uptake of deoxyglucose in our system. We report here that this increase was not impaired by IFN, thus suggesting that the early inhibitory effects of IFN on gene expression described in this work do not result from a decrease in the binding of PDGF to its cell-surface receptors. The IFN could, therefore, inhibit the transduction of the mitogenic signal from the membrane to the nucleus, and/or it could reduce the expression of the c-myc gene and of the other members of the competence gene family' by inducing some new intracellular mechanisms. The latter possibility is supported by our finding that at least part of the inhibitory effect of IFN on c-myc mRNA levels is sensitive to inhibitors of protein synthesis. In this respect, the effect of IFN basically differs from the effect exerted by the PDGF, which is completely independent of continuous protein synthesis. The requirement for protein synthesis could reflect the involvement of one of the products of the IFN-induced genes in c-myc inhibition. It is well established that IFN activates the transcription rate of several genes within minutes of its administration to cells (19, 20) . In accord with these data, we have recently shown that one representative product of this group of genes, the (2' ,5')oligoadenylate synthetase accumulates above basal levels in different compartments of the 3T3 cells, including the nuclear matrix, as early as 3 hr after exposure to IFN (unpublished results). The products of IFN-induced genes, therefore, have the potential to mediate early effects of IFN on cells. The induction of these genes, however, is transient (19, 20) and this could account for the failure of IFN to inhibit c-myc expression and two other PDGF-induced genes when it was administered to the 3T3 cells 48 hr prior to the PDGF (30) . It still remains to be determined whether the inhibitory effects of IFN on c-fos mRNA levels, which were detected in this work as early as 20 min after stimulation, depends at all on de novo protein synthesis.
Inhibitory effects of IFN on c-myc mRNA were also detected in Daudi Burkitt lymphoma and Molt-4 cells (16, 17, 31, 32) . In the case of the Daudi cell system, it has been reported that the inhibition resulted from either a transcriptional (16, 17) or a posttranscriptional level (32) , a difference that probably reflects variations within different Daudi cell lines. It will be interesting in the future to determine the level of c-myc inhibition in the BALB/c 3T3 system and to analyze the proteins involved in this effect. An important point in this respect would be to test whether the same IFN-mediated molecular mechanisms decrease c-myc mRNA levels in cycling cells that constitutively express the gene (e.g., Daudi and Molt-4) and in cells undergoing Go/Gj to S transition in which the gene is induced by PDGF. Once the putative molecular mechanisms are identified, then the basis of relaxed regulation displayed by many transformed cells that fail to respond to IFN by c-myc inhibition (16, 17) can be further analyzed and understood.
